Genmab A-S Aktie
| 256,10EUR | -3,20EUR | -1,23% |
WKN: 565131 / ISIN: DK0010272202
Personal
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 781 | 1 212 | 1 660 | 2 204 | 2 682 |
| Umsatz pro Mitarbeiter in Mio. EUR | 12,95 | 7,00 | 8,79 | 7,47 | 8,03 |
Bilanz (in Mio. DKK) - Aktiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 18 791 | 22 736 | 28 377 | 33 139 | 27 854 |
| Summe Anlagevermögen | 2 352 | 1 891 | 1 901 | 2 150 | 17 957 |
| Summe Aktiva | 21 143 | 24 627 | 30 278 | 35 289 | 45 811 |
Bilanz (in Mio. DKK) - Passiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 2 022 | 2 431 | 2 837 | 3 679 | 9 114 |
| Summe Eigenkapital | 19 121 | 22 196 | 27 441 | 31 610 | 36 697 |
| Summe Passiva | 21 143 | 24 627 | 30 278 | 35 289 | 45 811 |
Adresse
| Carl Jacobsens Vej 30, 2500 Copenhagen | |
| Internet | http://www.genmab.com |
Management
|
Anders Gersel Pedersen
Non-Independent Director |
|
Andrew Carlsen
Vice President & Head-Investor Relations |
|
Anthony Pagano
Chief Financial Officer & Executive Vice President |
|
Brad Bailey
Chief Commercial Officer & Executive VP |
|
Christopher Cozic
Chief People Officer & Executive Vice President |
|
Deirdre P. Connelly
Chairman |
|
Elizabeth G. O'Farrell
Independent Director |
|
Gregory David Emil Mueller
Chief Legal Officer, EVP & General Counsel |
|
Jan G. J. van de Winkel
President & Chief Executive Officer |
|
Judith Klimovsky
Chief Development Officer & Executive VP |
|
Marisol Peron
SVP-Global Communications & Corporate Affairs |
|
Martin Schultz
Non-Independent Director |
|
Martine J. van Vugt
Chief Strategy Officer & Executive Vice President |
|
Michael Kavanagh
Director |
|
Mijke Zachariasse
Non-Independent Director |
|
Paolo Augusto Paoletti
Independent Director |
|
Pernille Lyngvold Erenbjerg
Deputy Chairman |
|
Rayne Waller
Chief Technical Operations Officer & Executive VP |
|
Rolf K. Hoffmann
Independent Director |
|
Tahamtan Ahmadi
Chief Medical Officer & Executive Vice President |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.